BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37330571)

  • 1. Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy.
    Wang Q; Chen C; Zuo S; Cao K; Li H
    J Transl Med; 2023 Jun; 21(1):395. PubMed ID: 37330571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-diversity microbiota and an increased metabolism of arginine and aromatic amino acids: a hallmark of hepatic encephalopathy in western Mexican patients with alcohol-associated cirrhosis.
    Baltazar-Díaz TA; Riggen-Bueno V; Cortina-Romero DB; Del Toro-Arreola S; Haramati J; Bastidas-Ramírez BE; Bueno-Topete MR
    J Appl Microbiol; 2023 Jun; 134(6):. PubMed ID: 37353925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of Microbacterial Diversity Is Associated with Functional Prognosis of Stroke.
    Zhang X; Wang X; Zhao H; Cao R; Dang Y; Yu B
    Neural Plast; 2023; 2023():6297653. PubMed ID: 37197229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy.
    Bloom PP; Luévano JM; Miller KJ; Chung RT
    Ann Hepatol; 2021; 25():100333. PubMed ID: 33621653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Gut Microbiome and Its Metabolites, Short-Chain Fatty Acids, in Children With Idiopathic Short Stature.
    Li L; Chen L; Yang Y; Wang J; Guo L; An J; Ma X; Lu W; Xiao Y; Wang X; Dong Z
    Front Endocrinol (Lausanne); 2022; 13():890200. PubMed ID: 35757432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy.
    Iebba V; Guerrieri F; Di Gregorio V; Levrero M; Gagliardi A; Santangelo F; Sobolev AP; Circi S; Giannelli V; Mannina L; Schippa S; Merli M
    Sci Rep; 2018 May; 8(1):8210. PubMed ID: 29844325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
    Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
    Front Immunol; 2020; 11():1994. PubMed ID: 32973805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal microbiota from patients with cirrhosis has a low capacity to ferment non-digestible carbohydrates into short-chain fatty acids.
    Jin M; Kalainy S; Baskota N; Chiang D; Deehan EC; McDougall C; Tandon P; Martínez I; Cervera C; Walter J; Abraldes JG
    Liver Int; 2019 Aug; 39(8):1437-1447. PubMed ID: 30919578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients.
    Ubachs J; Ziemons J; Soons Z; Aarnoutse R; van Dijk DPJ; Penders J; van Helvoort A; Smidt ML; Kruitwagen RFPM; Baade-Corpelijn L; Olde Damink SWM; Rensen SS
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2007-2021. PubMed ID: 34609073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study.
    Verhaar BJH; Collard D; Prodan A; Levels JHM; Zwinderman AH; Bäckhed F; Vogt L; Peters MJL; Muller M; Nieuwdorp M; van den Born BH
    Eur Heart J; 2020 Nov; 41(44):4259-4267. PubMed ID: 32869053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
    Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
    Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a GC-FID method for the analysis of short chain fatty acids in rat and human faeces and in fermentation fluids.
    Scortichini S; Boarelli MC; Silvi S; Fiorini D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Apr; 1143():121972. PubMed ID: 32193004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-chain fatty acids accompanying changes in the gut microbiome contribute to the development of hypertension in patients with preeclampsia.
    Chang Y; Chen Y; Zhou Q; Wang C; Chen L; Di W; Zhang Y
    Clin Sci (Lond); 2020 Jan; 134(2):289-302. PubMed ID: 31961431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GC-MS analysis of short chain fatty acids and branched chain amino acids in urine and faeces samples from newborns and lactating mothers.
    Ramos-Garcia V; Ten-Doménech I; Moreno-Giménez A; Campos-Berga L; Parra-Llorca A; Solaz-García Á; Lara-Cantón I; Pinilla-Gonzalez A; Gormaz M; Vento M; Kuligowski J; Quintás G
    Clin Chim Acta; 2022 Jul; 532():172-180. PubMed ID: 35545167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gut microbiota and its metabolites correlate with plasma cytokines in schizophrenia inpatients with aggression.
    Deng H; He L; Wang C; Zhang T; Guo H; Zhang H; Song Y; Chen B
    BMC Psychiatry; 2022 Sep; 22(1):629. PubMed ID: 36167540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS).
    Ratajczak W; Mizerski A; Rył A; Słojewski M; Sipak O; Piasecka M; Laszczyńska M
    Aging (Albany NY); 2021 Apr; 13(8):10934-10954. PubMed ID: 33847600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
    Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
    J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis.
    Wu Z; Zhou H; Liu D; Deng F
    Front Cell Infect Microbiol; 2023; 13():1218552. PubMed ID: 37483387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prebiotic administration modulates gut microbiota and faecal short-chain fatty acid concentrations but does not prevent chronic intermittent hypoxia-induced apnoea and hypertension in adult rats.
    O'Connor KM; Lucking EF; Bastiaanssen TFS; Peterson VL; Crispie F; Cotter PD; Clarke G; Cryan JF; O'Halloran KD
    EBioMedicine; 2020 Sep; 59():102968. PubMed ID: 32861200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.